科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/12/06 | 5,640 | 5,650 | 5,550 | 5,560 | -100 | -1.8% | 132,300 |
| 2017/12/05 | 5,650 | 5,690 | 5,640 | 5,660 | -20 | -0.4% | 119,400 |
| 2017/12/04 | 5,710 | 5,770 | 5,660 | 5,680 | -30 | -0.5% | 157,000 |
| 2017/12/01 | 5,690 | 5,730 | 5,640 | 5,710 | +90 | +1.6% | 234,900 |
| 2017/11/30 | 5,550 | 5,660 | 5,550 | 5,620 | +80 | +1.4% | 363,100 |
| 2017/11/29 | 5,540 | 5,560 | 5,500 | 5,540 | +20 | +0.4% | 183,000 |
| 2017/11/28 | 5,490 | 5,540 | 5,480 | 5,520 | +30 | +0.5% | 127,800 |
| 2017/11/27 | 5,570 | 5,580 | 5,470 | 5,490 | -60 | -1.1% | 215,200 |
| 2017/11/24 | 5,650 | 5,660 | 5,500 | 5,550 | -130 | -2.3% | 269,800 |
| 2017/11/22 | 5,810 | 5,820 | 5,670 | 5,680 | -90 | -1.6% | 132,700 |
| 2017/11/21 | 5,750 | 5,800 | 5,750 | 5,770 | +20 | +0.3% | 79,800 |
| 2017/11/20 | 5,710 | 5,770 | 5,630 | 5,750 | -60 | -1% | 241,900 |
| 2017/11/17 | 5,720 | 5,830 | 5,700 | 5,810 | +80 | +1.4% | 215,400 |
| 2017/11/16 | 5,640 | 5,730 | 5,640 | 5,730 | +80 | +1.4% | 215,300 |
| 2017/11/15 | 5,770 | 5,770 | 5,650 | 5,650 | -130 | -2.2% | 168,900 |
| 2017/11/14 | 5,800 | 5,830 | 5,780 | 5,780 | -20 | -0.3% | 105,100 |
| 2017/11/13 | 5,840 | 5,860 | 5,770 | 5,800 | ±0 | ±0% | 167,500 |
| 2017/11/10 | 5,740 | 5,820 | 5,740 | 5,800 | -40 | -0.7% | 147,800 |
| 2017/11/09 | 5,840 | 5,940 | 5,800 | 5,840 | +10 | +0.2% | 294,100 |
| 2017/11/08 | 5,760 | 5,840 | 5,630 | 5,830 | -10 | -0.2% | 342,000 |
| 2017/11/07 | 5,720 | 5,880 | 5,690 | 5,840 | +140 | +2.5% | 220,400 |
| 2017/11/06 | 5,720 | 5,870 | 5,660 | 5,700 | -90 | -1.6% | 326,000 |
| 2017/11/02 | 5,870 | 5,880 | 5,790 | 5,790 | -30 | -0.5% | 136,800 |
| 2017/11/01 | 5,780 | 5,850 | 5,770 | 5,820 | +80 | +1.4% | 175,800 |
| 2017/10/31 | 5,680 | 5,750 | 5,670 | 5,740 | +10 | +0.2% | 130,100 |
| 2017/10/30 | 5,770 | 5,790 | 5,730 | 5,730 | -80 | -1.4% | 362,000 |
| 2017/10/27 | 5,820 | 5,830 | 5,770 | 5,810 | -20 | -0.3% | 178,600 |
| 2017/10/26 | 5,870 | 5,870 | 5,800 | 5,830 | -10 | -0.2% | 93,800 |
| 2017/10/25 | 5,920 | 5,920 | 5,830 | 5,840 | -50 | -0.8% | 109,100 |
| 2017/10/24 | 5,860 | 5,910 | 5,860 | 5,890 | +10 | +0.2% | 112,700 |
| 2017/10/23 | 5,940 | 5,940 | 5,870 | 5,880 | -30 | -0.5% | 126,200 |
| 2017/10/20 | 5,940 | 5,940 | 5,860 | 5,910 | -10 | -0.2% | 136,200 |
| 2017/10/19 | 5,950 | 5,960 | 5,890 | 5,920 | ±0 | ±0% | 133,300 |
| 2017/10/18 | 5,780 | 5,940 | 5,780 | 5,920 | +180 | +3.1% | 276,000 |
| 2017/10/17 | 5,720 | 5,740 | 5,680 | 5,740 | +20 | +0.3% | 159,700 |
| 2017/10/16 | 5,700 | 5,740 | 5,680 | 5,720 | +40 | +0.7% | 248,400 |
| 2017/10/13 | 5,680 | 5,710 | 5,640 | 5,680 | -20 | -0.4% | 192,900 |
| 2017/10/12 | 5,720 | 5,720 | 5,680 | 5,700 | +10 | +0.2% | 206,600 |
| 2017/10/11 | 5,710 | 5,750 | 5,680 | 5,690 | -10 | -0.2% | 167,600 |
| 2017/10/10 | 5,690 | 5,730 | 5,680 | 5,700 | ±0 | ±0% | 180,400 |
| 2017/10/06 | 5,680 | 5,700 | 5,660 | 5,700 | ±0 | ±0% | 129,400 |
| 2017/10/05 | 5,700 | 5,720 | 5,690 | 5,700 | +10 | +0.2% | 96,200 |
| 2017/10/04 | 5,750 | 5,760 | 5,680 | 5,690 | -60 | -1% | 123,000 |
| 2017/10/03 | 5,770 | 5,770 | 5,700 | 5,750 | +10 | +0.2% | 168,200 |
| 2017/10/02 | 5,760 | 5,780 | 5,720 | 5,740 | +20 | +0.3% | 126,500 |
| 2017/09/29 | 5,720 | 5,750 | 5,690 | 5,720 | -10 | -0.2% | 135,300 |
| 2017/09/28 | 5,810 | 5,820 | 5,710 | 5,730 | -60 | -1% | 190,200 |
| 2017/09/27 | 5,820 | 5,840 | 5,770 | 5,790 | -100 | -1.7% | 102,200 |
| 2017/09/26 | 5,800 | 5,900 | 5,800 | 5,890 | +90 | +1.6% | 127,900 |
| 2017/09/25 | 5,780 | 5,810 | 5,760 | 5,800 | +40 | +0.7% | 74,400 |
1801～
1850
件表示中 / 3686件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 413,300円 | +30.5% | +111.0% | 4.60% | 11.65倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 361,300円 | +7.9% | +8.9% | 3.43% | 7.73倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 188,000円 | +5.0% | +1.5% | 0.00% | 16.14倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 384,500円 | +14.5% | -2.3% | 2.34% | 14.07倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 208,800円 | - | - | 0.00% | - | 96.71倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
